Company profile: Yecuris
1.1 - Company Overview
Company description
- Provider of FRG KO liver-humanized mouse models and tools for applications including gene editing, drug metabolism, toxicology, and liver disease. Offers HepaCur human hepatocytes (fresh/cryopreserved), CuRx reagents for the FRG KO platform, gene and cell therapy services (in vitro/in vivo validation, custom hepatocyte transplantation), plus NASH/NAFLD and infectious disease models; reagents ship worldwide.
Products and services
- FRG® KO Mouse Models: Proprietary liver-humanized FRG® KO mouse models enable gene editing studies, drug metabolism profiling, toxicology assessments, and liver disease research across preclinical workflows
- Gene & Cell Therapy Services: Custom-engineered gene and cell therapy platform architects in vitro development, executes in vivo validation, and performs custom hepatocyte transplantation for rigorous therapeutic verification
- HepaCur™ Hepatocytes: Research-grade HepaCur™ human hepatocytes, freshly isolated or cryopreserved, support in vitro experiments and in vivo research applications requiring human liver cells
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Yecuris
Circulomics
HQ: United States
Website
- Description: Provider of micro- and nanotechnology-driven solutions for nucleic acid sample preparation and long-read sequencing, offering Nanobind high molecular weight DNA extraction from plant, animal, and microbial samples, library preparation protocols, services for single chromosomal genome assemblies, and applications leveraging optical mapping for genome structure analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Circulomics company profile →
Invitae
HQ: United States
Website
- Description: Provider of medical genetics services delivering comprehensive genetic information to guide healthcare decisions. Offers genetic testing for diseases and medical conditions; genetic counseling at no additional cost in specified regions; a Billing Assurance Program for cost-effective payment options; Invitae Generation using advanced machine learning for testing and classification; proactive health tests focusing on cancer and cardiovascular conditions; and sponsored no-charge testing via biopharma partnerships.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Invitae company profile →
GeneThera
HQ: United States
Website
- Description: Provider of biotechnology applying molecular technologies to improve food safety and eradicate zoonotic diseases, including Johne's Disease, Mad Cow Disease, Chronic Wasting Disease, and E.coli, affecting terrestrial, avian, and aquatic animals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GeneThera company profile →
GenEdit
HQ: United States
Website
- Description: Provider of a proprietary non-viral, non-lipid polymer nanoparticle platform (NanoGalaxy) for safe, efficient delivery of genetic medicine payloads—including nucleic acids, therapeutic proteins, and CRISPR/Cas9—to specific tissues. Offers tissue selectivity, payload flexibility, ability to redose without immune response, and scalable manufacturing with batch-to-batch purity and long-term stability that reduces cold-chain logistics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GenEdit company profile →
CropDesign
HQ: Belgium
Website
- Description: Provider of agricultural biotechnology solutions delivering genetic traits for the global seed market and plant-based products. Uses its proprietary TraitMillTM platform to discover traits that improve corn, rice, and other plants; offers crops like corn and rice to the seed market. Founded in 1998, employs more than 70 people at research facilities in Gent, Belgium.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CropDesign company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Yecuris
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Yecuris
2.2 - Growth funds investing in similar companies to Yecuris
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Yecuris
4.2 - Public trading comparable groups for Yecuris
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →